RELAPSED OR REFRACTORY PRIMARY MYELOFIBROSIS

Clinical trials for RELAPSED OR REFRACTORY PRIMARY MYELOFIBROSIS explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY PRIMARY MYELOFIBROSIS trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY PRIMARY MYELOFIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for tough blood cancers: early drug trial seeks to control disease

Disease control Ongoing

This early-stage study is testing a new drug called INCB057643, both alone and in combination with an existing drug (ruxolitinib), in adults with advanced blood cancers like myelofibrosis. The main goal is to check if the treatment is safe and tolerable. Researchers will also loo…

Matched conditions: RELAPSED OR REFRACTORY PRIMARY MYELOFIBROSIS

Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

RELAPSED OR REFRACTORY PRIMARY MYELOFIBROSIS

Get alerted when new RELAPSED OR REFRACTORY PRIMARY MYELOFIBROSIS trials appear

New hope for tough blood cancers: early drug trial seeks to control disease